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bleeds and decreased cognitive abilities have been primar-
ily cross-sectional. Here, we used a retrospective longitudi-
nal design to examine whether the presence of lobar 
microbleeds is associated with the rate of cognitive decline 
among non-demented older adults.  Methods: Participants 
came from an ongoing longitudinal community-based ag-
ing study, in which subjects are evaluated at 18–24 months 
intervals and received a full medical, neurological, and neu-
ropsychological examination at each of the follow-up visits. 
Gradient echo MRI scans were available on 197 non-dement-
ed participants (mean age: 84.15 ± 5.02 years). Microbleeds 
were rated visually on axial view and divided into subcortical 
(basal ganglia, cerebellum) and lobar (frontal, temporal, pa-
rietal, occipital lobe) regions, and confirmed with coronal 
and sagittal views to exclude artifacts. Cognition was as-
sessed with a neuropsychological battery, providing sum-
mary scores for memory, language, executive, and visuospa-
tial abilities. Using general estimating equations (GEE), we 
compared cognition cross-sectionally between individuals 
 Key Words 
 Microbleeds · Cognition · Cerebral amyloid angiopathy · 
MRI · Longitudinal design 
 Abstract 
 Background: Normal aging is associated with a decline in 
cognitive abilities, particularly in the domains of psychomo-
tor speed and executive functioning. However, ‘aging,’ per 
se, is not a cause of cognitive decline but rather a variable 
that likely captures multiple accumulating biological chang-
es over time that collectively affect mental abilities. Recent 
work has focused on the role of cerebrovascular disease as 
one of the biological changes. In the current study, we exam-
ined whether lobar microbleeds – magnetic resonance im-
aging (MRI) signal voids due to hemosiderin deposits sec-
ondary to cerebral amyloid angiopathy – are associated with 
cognitive decline in normal aging. Previous studies that re-
ported a relationship between the presence of lobar micro-
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with 2 or more (n = 11) and fewer than 2 (n = 186) lobar mi-
crobleeds and examined longitudinal cognitive change be-
ginning 9.47 ± 3.13 years before the MRI scan.  Results: Sub-
jects with 2 or more lobar microbleeds had worse executive 
functioning at the visit closest to the MRI scan (β = –0.044; 
p < 0.001)  and had a faster decline in executive function over 
time (β = –0.072; p = 0.012) than subjects with fewer than 2 
lobar microbleeds. The two groups were similar in age at 
scan date, education, ethnicity, sex distribution, and cogni-
tive performance at first visit.  Conclusions: Lobar micro-
bleeds, a marker of cerebral amyloid angiopathy, are associ-
ated with an accelerated rate of executive function decline. 
The presence of cerebral amyloid angiopathy may be an im-
portant source of cognitive decline in aging. Future work 
should examine how cerebral amyloid angiopathy interacts 
with neurodegenerative processes, such as Alzheimer’s dis-
ease.  © 2014 S. Karger AG, Basel 
 Introduction 
 Over the past several decades, there have been myriad 
efforts to characterize the nature of age-associated cogni-
tive decline. Most studies agree that aging is associated 
with a gradual loss of cognitive abilities, with increasing 
variability or individual differences  [1–3] particularly in 
the domains of psychomotor speed and executive func-
tion  [4] . ‘Aging’, per se, is not a cause of cognitive decline 
but rather a variable that likely captures multiple accu-
mulating biological changes over time that collectively af-
fect mental abilities.
 There are currently no accepted definitions of what 
constitutes ‘normal’ versus ‘pathological’ cognitive aging. 
Typically, we consider normal cognitive aging as a decline 
in certain cognitive abilities in the absence of frank dis-
ease or evidence of neurodegenerative pathology  [5] . Sev-
eral authors have argued that small vessel cerebrovascular 
disease is a primary source of normal cognitive aging  [6–
8] . ‘Pathological cognitive aging’, on the other hand typi-
cally refers to cognitive decline that is due to a neurode-
generative condition  [9] . In the case of Alzheimer’s dis-
ease (AD), the most common cause of pathological aging, 
current hypothetical pathogenic models emphasize the 
precipitating role of fibrillar forms of beta amyloid pro-
tein and tau pathology, which ultimately cause neurode-
generation and the neuropsychological syndrome associ-
ated with the disease  [10] . The amyloid cascade hypoth-
esis suggests that imbalance of production and clearance 
of Aβ is a primary driver of pathological cognitive aging.
 Recent literature, however, implicates small vessel 
cerebrovascular disease as an important source of dys-
function in AD and perhaps disease pathogenesis  [8] , sug-
gesting some overlap between factors that promote cogni-
tive decline due to normal aging and due to AD. Cerebral 
amyloid angiopathy (CAA), or the deposition of beta am-
yloid in blood vessel walls, may represent a mechanistic 
link between amyloid-centered hypothesis and the in-
creasing attention toward vascular factors in AD patho-
genesis – promoting cognitive decline in individuals with-
out dementia but also contributing to the pathogenesis of 
AD. Cerebral amyloid angiopathy manifests radiological-
ly as cerebral microbleeds (MB) distributed in lobar re-
gions on gradient echo (GRE) and susceptibility weighted 
(SWI) magnetic resonance imaging (MRI)  [11, 12] . Thus, 
lobar microbleeds are considered a radiological indicator 
of the presence of underlying CAA, and associations with 
clinical characteristics involving microbleeds can be at-
tributed to the role of the underlying amyloid pathology.
 Previous studies showed that lobar microbleeds are as-
sociated with reduced cognition cross-sectionally  [13–
15] , and that individuals with AD have a greater number 
of lobar microbleeds  [16] and CAA  [17] compared with 
healthy individuals. However, efforts to examine longitu-
dinal cognitive change as a function of microbleed status 
are scarce and have only been carried out in clinical pop-
ulations  [18] . There are no studies to our knowledge that 
have examined the association of CAA, appreciated ra-
diologically as lobar microbleeds, and longitudinal cogni-
tive change among non-demented older adults. In the 
current study, we used a retrospective longitudinal design 
to examine whether community-dwelling individuals 
with 2 or more lobar microbleeds, as an indicator of CAA, 
had a more precipitous rate of cognitive change than in-
dividuals with fewer than 2 lobar microbleeds.
 Materials and Methods 
 Participants 
 Subjects were participants in an ongoing longitudinal commu-
nity-based study of aging and dementia in northern Manhattan, 
which had two recruitment waves beginning in 1992 and 1999. 
Participants were all English or Spanish speaking, over age 65, and 
either White, Hispanic, or African American. Recruitment proce-
dures and sampling strategies have been described in detail previ-
ously  [19] . Participants were evaluated at 18–24 month intervals 
and they received a full medical, neurological, and neuropsycho-
logical examination at each of the follow-up visits. A history of 
hypertension was ascertained by self-report  [20] . Beginning in 
2005, participants not meeting criteria for dementia at their previ-
ous follow-up visit were invited to participate in an MRI study  [21] . 
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Seven hundred sixty-nine participants underwent high-resolution 
initial MRI.
 Beginning in 2009, participants with initial MRI scans were in-
vited for a follow-up MRI scan, leading to a total of 339 subjects 
with repeat MRI; 243 of the 339 had T2 * -weighted gradient echo 
(GRE) scans for microbleed assessment  [22] . For the current anal-
ysis, we examined cognition data starting in 1999 and excluded 
subjects meeting clinical criteria for dementia at the time of the 
GRE MRI scan (n = 46), resulting in a sample of 197 subjects (mean 
age: 84.15 ± 5.02 years) that comprised the study group reported 
here. The average time between the baseline cognitive assessment 
and the subjects’ GRE MRI scan was 9.47 (SD = 3.13) years, with 
an average of 4.7 visits per subject (range: 3–11). The GRE MRI 
scan was conducted at the visit closest to the last neuropsycho-
logical examination included in the current study.
 MRI Protocol 
 High-resolution, three-dimensional T2 * -weighted GRE imag-
es (TR = 45 ms, TE = 31 ms, flip angle = 13, slice thickness = 2 mm, 
in plane resolution 1 × 1 mm) were acquired on a Philips Intera 1.5 
Tesla MRI scanner (Best, the Netherlands) for microbleed quanti-
fication. Microbleeds were rated by visual inspection following the 
criteria put forth by the Microbleed Study Group  [11] : dark, round 
lesions on GRE images within the parenchyma and at least half way 
surrounded by a white rim. They were rated on axial slices, and 
confirmed by visual inspection of corresponding sagittal and coro-
nal planes to exclude artifacts such as calcium deposits, partial vol-
ume artifacts, cavernous malformations, bone, or vessel flow voids. 
Microbleeds were divided into ‘lobar’ (frontal, temporal, parietal, 
occipital lobes) or ‘deep’ (basal ganglia, thalamus, and cerebellum) 
categories. Number and location of microbleeds were recorded for 
each subject. All microbleeds were evaluated by a single blinded 
operator (IBM) after establishing excellent reliability with a ‘gold 
standard’ rater (SMR; intra-class correlation for reliability analysis 
of 20 images = 0.94).
 We divided our sample into two groups: subjects with zero or 
one (<2) lobar microbleeds and subjects with two or more (2+) 
lobar microbleeds, indicating evidence of CAA. By focusing on 
individuals with 2 or more lobar microbleeds, we increased our 
confidence that the experimental group had evidence of CAA be-
cause multiple lobar lesions are a strong indicator of underlying 
pathology and a single lesion is not uncommon among individuals 
without pathological evidence of CAA  [23] .
 As previously described  [22] , total white matter hyperintensi-
ties (WMH) volumes were calculated for concurrent MRI scans 
and the presence of radiological infarcts was evaluated at the sub-
jects’ baseline MRI scan.
 Neuropsychological Evaluation 
 Cognitive performance was assessed with a comprehensive 
neuropsychological battery, and summary scores for the domains 
memory, language, speed/executive functioning, and visuospatial 
abilities were derived. Summary scores were calculated through 
exploratory and confirmatory factor analyses and represented on 
a z-distribution  [24] .
 Statistical Analyses 
 We compared the demographic characteristics at the time of 
scan and the first cognitive test performance between individuals 
with fewer than two (<2) (n = 186) and individuals with two or 
more (2+) lobar microbleeds (n = 11). A retrospective longitudinal 
design was used to examine the rates of cognitive decline preceding 
the MRI scan, beginning 9.47 (±3.13) years prior to the scan, as a 
function of the microbleed group, using general estimating equa-
tions (GEE)  [25] . The primary effects of interest in the GEE mod-
el include Group, Time, and the Group × Time interaction. A main 
effect of Time would indicate a significant change in cognitive abil-
ities over time. A significant Group effect would indicate that sub-
jects with two or more lobar microbleeds differ from subjects with 
fewer than two lobar microbleeds at the time of first visit (inter-
cept). A significant Group × Time interaction would indicate that 
the rate of cognitive change over time differs between the two mi-
crobleeds groups. We ran separate analyses for summary measures 
of memory, language, speed/executive functioning, and visuospa-
tial abilities. The variables age at MRI scan, years of education, 
ethnicity, sex, and cognitive domain scores at baseline were en-
tered into the GEE model as covariates.
 Results 
 Individuals in the two groups were similar in age at 
scan date, education, ethnicity, sex distribution, frequen-
cy of hypertension, and cognitive performance at the time 
of the first visit ( table 1 ). The prevalence of microbleeds 
in the entire sample was 27.2%. The 11 subjects with 2+ 
lobar microbleeds had a mean number of 4.45 micro-
bleeds (±3.205). In the <2 microbleeds group, 30 subjects 
had one lobar microbleed and 156 subjects had no micro-
bleeds. Six subjects had both deep and lobar microbleeds. 
We re-ran the analyses excluding these subjects and the 
reported effects did not change notably. Individuals with 
2+ lobar microbleeds had greater total WMH volumes 
and were more likely to have a radiological infarct than 
individuals with <2 lobar microbleeds.
 Table 2 displays the results of the GEE analysis. For 
speed/executive functioning, both groups declined over 
time (significant main effect of Time) but participants 
with 2+ lobar microbleeds declined at a faster rate than 
those with <2 lobar microbleeds (significant Group × 
Time interaction; see  fig. 1 ). The two groups had similar 
speed/executive functioning performance at their first as-
sessment (nonsignificant main effect of Group). Of the 
covariates in the model, age, education, baseline cogni-
tion, but not sex were associated with speed/executive 
functioning.
 For the other cognitive domains, the rate of cognitive 
decline was similar between the two microbleeds groups 
(nonsignificant Group × Time effects). Like for speed/
executive functioning, both groups declined in memory 
and language, but not visuospatial functioning over time 
(significant main effects of Time). The two microbleeds 
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Table 1.  Subject demographic data
  <2 lobar 
microbleeds
(n = 186)
2+ lobar 
microbleeds
(n = 11)
Total sample
(n = 197)
Statistic
Age at date of MRI scan 84.14±5.06 84.39±4.44 84.15±5.02 t = 0.619; p = 0.871
Education, years (mean ± SD) 11.84±4.65 10.00±6.73 11.75±4.78 t = 1.190; p = 0.235
Speed/executive function at first visit (mean ± SD) 0.48±0.06 0.19±0.51 0.46±0.92 t = 0.965; p = 0.336
Memory at first visit (mean ± SD) 0.54±0.58 0.28±0.76 0.53±0.59 t = 1.447; p = 0.150
Language at first visit (mean ± SD) 0.49±0.55 0.48±0.67 0.49±0.55 t = 0.088; p = 0.930
Visuospatial functioning at first visit (mean ± SD) 0.49±0.51 0.38±0.66 0.48±0.52 t = 0.699; p = 0.485
Sex (% women) 68.2 60.0 67.52 X2 = 0.517; p = 0.350
Ethnicity (% African American/Hispanic/White) 34/27/39 46/33/21 35/29/36 X2 = 1.992; p = 0.369
Hypertension, n (%) 124 (66%) 10 (91%) 134 (68%) X2 = 2.81; p = 0.09
WMH volume, log transformed, cm3 (mean ± SD) 1.46±1.30 2.31±1.02 1.48±1.48 t = 2.40; p = 0.039
Radiological infarct, n (%) 50 (27%) 6 (55%) 56 (28%) X2 = 3.85; p = 0.05
Table 2.  GEE analyses for the domains speed, memory, language, and visuospatial functioning
Variable Speed/executive
function
Memory Language  Visuospatial
β p β p β p β p
Group (0 = <2 microbleeds,
1 = 2+ microbleeds) –0.392 0.108 0.122 0.307 –0.055 0.660 0.001 0.857
Time –0.044 <0.001 –0.028 <0.001 –0.010 0.003 –0.061 0.699
Group × time –0.072 0.012 0.016 0.288 –0.005 0.793 0.026 0.137
Age –0.013 0.013 –0.014 0.002 –0.010 0.001 –0.007 0.009
Sex (0 = M, 1 = F) –0.006 0.912 0.097 0.050 0.047 0.113 0.057 0.039
Education 0.017 0.019 0.015 0.024 0.014 0.019 0.021 <0.001
Baseline cognition 0.774 <0.001 0.726 <0.001 0.804 <0.001 0.686 <0.001
Beta values are standardized.
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 Fig. 1. Differential decline in speed/execu-
tive functioning among individuals with 2 
or more microbleeds versus controls. Plot-
ted results of GEE model examining the 
Group × Time interaction for the cognitive 
domain of speed/executive function, ad-
justed for age, education, ethnicity, sex, 
and cognitive performance at first visit. 
The MRI scan for microbleed assessment 
was completed at year 0. 
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groups were similar in their abilities at baseline (non-sig-
nificant main effects of Group). Age, education, and base-
line cognitive performance were associated with memo-
ry, language, and visuospatial functioning (see  table 2 ). 
Sex was related only to visuospatial functioning.
 Discussion 
 We used a retrospective longitudinal design to assess 
the relationship between lobar microbleeds, as a marker 
of cerebral amyloid angiopathy, and cognitive decline. In-
dividuals with 2 or more lobar microbleeds had an accel-
erated rate of speed/executive function decline over the 
9-year period preceding the MRI scan relative to individu-
als with fewer than 2 microbleeds. Unsurprisingly and as 
we have reported previously  [22] , individuals with more 
than 2 microbleeds also had increased evidence of isch-
emic cerebrovascular disease (i.e., WMH and infarct).
 Our findings of reduced cognition in the presence of 
lobar microbleeds are consistent with previous reports: 
lobar microbleeds have been associated with decreased 
overall cognitive status, as well as lower cognitive abilities 
in specific domains such as psychomotor speed and ex-
ecutive function  [14, 26–28] . Werring and colleagues  [13] 
found that 60% of individuals with lobar microbleeds had 
executive dysfunction compared with 30% without mi-
crobleeds. Lobar microbleeds also predicted executive 
functioning impairment 6 years later in a sample of stroke 
patients  [18] . Furthermore, lobar microbleeds are associ-
ated with executive impairment in patients with ischemic 
stroke and transient ischemic attack  [29] .
 Our study extends these findings by examining the 
longitudinal cognitive course of neurologically healthy 
individuals with and without evidence of cerebral amy-
loid angiopathy. Although the retrospective design pre-
cludes the ability to determine whether the development 
of the lobar microbleeds preceded the cognitive out-
comes, the findings do establish a relationship between 
the two. That is, we are unable to conclude definitively 
whether the microbleeds potentiated more rapid cogni-
tive decline or whether the cognitive decline preceded the 
microbleeds. The second possibility would suggest that 
additional factors promote the more rapid cognitive de-
cline and also lead to the development of lobar micro-
bleeds. Prospective analyses will help us determine 
whether lobar microbleeds promote subsequent cogni-
tive decline in this cohort.
 We observed an association of lobar microbleeds with 
a decline in speed/executive functioning but not in other 
cognitive domains. Speed or executive tasks may be most 
sensitive to vascular pathology or subtle age-associated 
brain changes in general  [30] . Further, accelerated de-
cline in executive functioning may be a harbinger for 
future decline in cognition related to AD. It is notewor-
thy that among cognitively normal adults above age 60, 
fibrillar forms of beta amyloid, as measured by positron 
emissions tomography, was related to reductions in 
measures of processing speed, working memory, and 
reasoning, but not declarative memory, a hallmark fea-
ture of frank AD  [31] . In the current study, we appear to 
have a similar association between vascular forms of beta 
amyloid and reduction in speeded tasks and executive 
abilities in non-demented older adults. Whether vascu-
lar and fibrillar forms of beta amyloid reflect the same 
pathological process and contribute independently to 
cognitive outcomes remains an important question. The 
fact that both can be present in non-demented older 
adults and are related to variability in cognition and cog-
nitive decline provides compelling evidence that differ-
ences between ‘normal’ and ‘pathological’ cognitive ag-
ing may be more a question of degree than of categorical 
distinction.
 Relatively a few participants in the study had evidence 
of cerebral amyloid angiopathy by virtue of having two or 
more lobar microbleeds, but this observation is consistent 
with what has been reported in previous community-
based cohorts  [27] . It should be noted that while deep 
microbleeds appear to reflect primarily injury associated 
with hypertensive vasculopathy, lobar microbleeds, 
which are the focus of the current study, primarily reflect 
CAA but could also be impacted by ischemia  [32] . Al-
though reliable changes in cognition were observed 
among those with two or more lobar microbleeds, we may 
have had limited power to detect change in other do-
mains. Furthermore, the relatively low field strength of 
the MRI scanner used may have led to an underestima-
tion of the number of microbleeds and could account for 
the few subjects with two or more microbleeds. On the 
other hand, because of the low field strength, we can be 
confident that individuals displaying 2 or more lobar mi-
crobleeds do in fact have some degree of CAA. Further-
more, our sample is typical of the demography that in-
creasingly comprises the older segment of the US popula-
tion: racially and ethnically diverse individuals with a 
range of educational background. Previous efforts that 
examined associations between lobar microbleeds and 
cognition generally did so among clinical patients with 
history of stroke (e.g.,  [18] ); our findings show that CAA 
is a source of cognitive decline even among community-
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dwelling older adults that were recruited with epidemio-
logical methods.
 Similarly, the small number of subjects with 2 or more 
detectable lobar microbleeds coupled with the relatively 
high number of covariates included in the GEE models 
may raise some concern about the reliability of the find-
ings. To address this issue, we selected 11 individuals with 
<2 lobar microbleeds matched on cognition at first visit, 
age, education, and sex and re-analyzed the data without 
demographic covariates (data not shown). The observed 
effects in this limited sample were of the same magnitude 
as those observed in the presented analyses above, in-
creasing confidence in our findings.
 We were able to exploit over 9 years of longitudinal 
data to examine associations between the rates of cogni-
tive decline and evidence of CAA at a single time point. 
To our knowledge, this is the first study to examine the 
longitudinal course of cognition as it relates to CAA in 
community-dwelling older adults. Our observations have 
significant theoretical and clinical implications. The find-
ings highlight that pathological changes in normal aging 
and AD may be less distinct than previously thought. That 
is, vascular forms of beta amyloid, one of the primary 
pathological features of AD, are prevalent among older 
adults and predict rate of ‘normal’ cognitive decline. This 
shared pathology between individuals with and without 
dementia due to AD highlights that there are other factors, 
besides amyloid, that might potentiate the neuropsycho-
logical syndrome that leads to dementia. Nonetheless, mi-
crobleeds may be a logical clinical treatment or preventive 
target to consider when designing studies or interventions 
to maximize cognitive aging in general. Further, clinicians 
should take into account the potential role of microbleeds 
in diagnostic and prognostic formulations.
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